Veterinary Pharmacovigilance Market Worth $1.89 Billion By 2030

Veterinary Pharmacovigilance Market Growth & Trends

The global veterinary pharmacovigilance market size is expected to reach USD 1.89 billion by 2030, registering a CAGR of 13.49% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is driven by several factors, including the increasing incidence of adverse drug reactions in animals, the rising adoption of companion animals, and the growing demand for animal-derived food products. Additionally, the increasing regulatory scrutiny and the need for stringent safety standards have led to the development of new pharmacovigilance technologies and tools. Accenture for instance, offers a range of Veterinary Vigilance services that include ICSR Case Processing , VeDDRA Coding, Signal Detection, Literature Management, EvVetMPD support, and Regulatory Intelligence. Growing industry requirements for aggregate reporting, expedited reporting, and management of signals are expected to propel the market growth in the coming years.

The COVID-19 pandemic has had both negative and positive impacts on the animal health market While it has created challenges, it has also created opportunities for companies to adapt and innovate, and has highlighted the importance of monitoring the safety and efficacy of animal health products in the context of global health crises. This supported the awareness and adoption of veterinary pharmacovigilance solutions. The field is an emerging sector within the animal healthcare market. It involves monitoring the safety and effectiveness of veterinary medicines, vaccines, and other animal health products, and reporting any adverse reactions or incidents that may occur. This information is then used to improve the safety and quality of these products and to protect animal health.With the growing concern for animal welfare and the increasing demand for animal-based food products, the market has gained significant attention in recent years.

Initiatives by key market participants is another factor fueling the market growth. In June 2018, Medfiles opened a new office in Japan to cater to European and Japanese clients with a range of services. These include pharmacovigilance, clinical trials, and analytical services, among others. In February 2022, Ennov, a key market player opened a new office in the U.S. in response to successful growth in the North American market. This expanded the company’s global footprint with a focus on building its pharmacovigilance capabilities. Ennov’s pharmacovigilance offerings include case intake, triage, signal detection and management for customers from human and veterinary life sciences market.

 Request a free sample copy or view report summary: Veterinary Pharmacovigilance Market Report

Veterinary Pharmacovigilance Market Report Highlights

• One of the key trends in the veterinary pharmacovigilance market is the adoption of new technologies such as electronic reporting systems and data analytics tools. These technologies allow for more efficient and accurate monitoring of adverse events, and can help to identify potential safety issues before they become more serious.

• By solution, software segment dominated the market in 2022, while services are expected to grow at the fastest CAGR of about 14%.

• By product, anti-infectives held the largest share of over 45% of the market in 2022. Biologics segment on the other hand, is estimated to grow at the highest rate of over 14% over the next few years.

• In-house segment held the dominant share of the market in 2022 in terms of type, while contract outsourcing is anticipated to grow at a notable rate of over 10%.

• Dogs accounted for the largest share of the market in 2022 by animal type. Other animal types are projected to grow at the fastest rate of about 15% in the coming years.

• North America dominated the market by region in 2022 with a share of about 40%. Asia Pacific region is estimated to grow at the fastest rate of over 15% from 2023 to 2030.

• The veterinary pharmacovigilance market presents significant opportunities for companies that are able to innovate, differentiate themselves, and respond to the evolving needs of the animal health industry.

Veterinary Pharmacovigilance Market Segmentation

Grand View Research has segmented the global Veterinary Pharmacovigilance market based on animal type, solution, type, product, and region:

Veterinary Pharmacovigilance Solution Outlook (Revenue, USD Million, 2018 - 2030)

• Software

• Services

Veterinary Pharmacovigilance Product Outlook (Revenue, USD Million, 2018 - 2030)

• Biologics

• Anti-infectives

• Other Product

Veterinary Pharmacovigilance Type Outlook (Revenue, USD Million, 2018 - 2030)

• In-house

• Contract Outsourcing

Veterinary Pharmacovigilance Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

• Dogs

• Cats

• Other Animal Types

Veterinary Pharmacovigilance Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  •  U.K.

  •  Germany

  •  France

  •  Italy

  •  Spain

  •  Rest of Europe 

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia Pacific

• Latin America

  • Brazil

  • Rest of Latin America

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • Rest of MEA

List of Key Players of Veterinary Pharmacovigilance Market

• ArisGlobal 

• Accenture

• Ennov 

• Sarjen Systems Pvt. Ltd.

• Pharsafer Associates Limited

• Knoell

• Biologit

• Indivirtus

• Azierta Contract Science Support Consulting

• Oy Medfiles Ltd.